These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 20015470)

  • 21. Particle size distribution and evolution in tablet structure during and after compaction.
    Fichtner F; Rasmuson A; Alderborn G
    Int J Pharm; 2005 Mar; 292(1-2):211-25. PubMed ID: 15725568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of inhalable dry powder formulation of basic fibroblast growth factor.
    Ibrahim BM; Jun SW; Lee MY; Kang SH; Yeo Y
    Int J Pharm; 2010 Jan; 385(1-2):66-72. PubMed ID: 19853028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effervescent dry powder for respiratory drug delivery.
    Ely L; Roa W; Finlay WH; Löbenberg R
    Eur J Pharm Biopharm; 2007 Mar; 65(3):346-53. PubMed ID: 17156987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Near-infrared spectroscopic method for real-time monitoring of pharmaceutical powders during voiding.
    Barajas MJ; Cassiani AR; Vargas W; Conde C; Ropero J; Figueroa J; Romañach RJ
    Appl Spectrosc; 2007 May; 61(5):490-6. PubMed ID: 17555618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of particle properties on the flowability of ibuprofen powders.
    Liu LX; Marziano I; Bentham AC; Litster JD; White ET; Howes T
    Int J Pharm; 2008 Oct; 362(1-2):109-17. PubMed ID: 18652883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a micro-dosing system for fine powder using a vibrating capillary. Part 2. The implementation of a process analytical technology tool in a closed-loop dosing system.
    Chen X; Seyfang K; Steckel H
    Int J Pharm; 2012 Aug; 433(1-2):42-50. PubMed ID: 22564779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a laser diffraction method for the determination of the particle size of aerosolised powder formulations.
    Marriott C; MacRitchie HB; Zeng XM; Martin GP
    Int J Pharm; 2006 Dec; 326(1-2):39-49. PubMed ID: 16942848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimization of the aerosolization properties of an inhalation dry powder based on selection of excipients.
    Minne A; Boireau H; Horta MJ; Vanbever R
    Eur J Pharm Biopharm; 2008 Nov; 70(3):839-44. PubMed ID: 18620052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measurement of drug agglomerates in powder blending simulation samples by near infrared chemical imaging.
    Li W; Woldu A; Kelly R; McCool J; Bruce R; Rasmussen H; Cunningham J; Winstead D
    Int J Pharm; 2008 Feb; 350(1-2):369-73. PubMed ID: 17951017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experimental observations of dry powder inhaler dose fluidisation.
    Tuley R; Shrimpton J; Jones MD; Price R; Palmer M; Prime D
    Int J Pharm; 2008 Jun; 358(1-2):238-47. PubMed ID: 18457930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Near InfraRed Spectroscopy homogeneity evaluation of complex powder blends in a small-scale pharmaceutical preformulation process, a real-life application.
    Storme-Paris I; Clarot I; Esposito S; Chaumeil JC; Nicolas A; Brion F; Rieutord A; Chaminade P
    Eur J Pharm Biopharm; 2009 May; 72(1):189-98. PubMed ID: 19059338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design and in vitro performance testing of multiple air classifier technology in a new disposable inhaler concept (Twincer) for high powder doses.
    de Boer AH; Hagedoorn P; Westerman EM; Le Brun PP; Heijerman HG; Frijlink HW
    Eur J Pharm Sci; 2006 Jun; 28(3):171-8. PubMed ID: 16650739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of nanomechanical crystal properties on the comminution process of particulate solids in spiral jet mills.
    Zügner S; Marquardt K; Zimmermann I
    Eur J Pharm Biopharm; 2006 Feb; 62(2):194-201. PubMed ID: 16202574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential of carnuba wax in ameliorating brittle fracture during tableting.
    Uhumwangho MU; Okor RS; Adogah JT
    Pak J Pharm Sci; 2009 Jan; 22(1):58-61. PubMed ID: 19168422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aerosolization behavior of carrier-free L-leucine coated salbutamol sulphate powders.
    Raula J; Lähde A; Kauppinen EI
    Int J Pharm; 2009 Jan; 365(1-2):18-25. PubMed ID: 18789380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Roller compactor: The effect of mechanical properties of primary particles.
    Al-Asady RB; Osborne JD; Hounslow MJ; Salman AD
    Int J Pharm; 2015 Dec; 496(1):124-36. PubMed ID: 26024822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new formulation for orally disintegrating tablets using a suspension spray-coating method.
    Okuda Y; Irisawa Y; Okimoto K; Osawa T; Yamashita S
    Int J Pharm; 2009 Dec; 382(1-2):80-7. PubMed ID: 19686825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of size and density of particles on flow properties of granules.
    Czarnecki W; Szumiło M; Wasik D
    Acta Pol Pharm; 2009; 66(5):553-61. PubMed ID: 19894652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spherical agglomerates of lactose with enhanced mechanical properties.
    Lamešić D; Planinšek O; Lavrič Z; Ilić I
    Int J Pharm; 2017 Jan; 516(1-2):247-257. PubMed ID: 27866980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of ageing, grinding and preheating on the thermal behaviour of alpha-lactose monohydrate.
    Garnier S; Petit S; Mallet F; Petit MN; Lemarchand D; Coste S; Lefebvre J; Coquerel G
    Int J Pharm; 2008 Sep; 361(1-2):131-40. PubMed ID: 18617338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.